NCT02735369View on ClinicalTrials.gov

A Study Assessing Efficacy and Safety of OC-10X in the Treatment of PDR

PHASE2TerminatedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Proliferative Diabetic Retinopathy (PDR)
Interventions
DRUG

2% OC-10X

2% OC-10X

DRUG

Placebo Comparator

Placebo

Trial Locations (1)

1205

Bangladesh Eye Hospital, Dhaka

Sponsors
All Listed Sponsors
collaborator

Semler Research Center Pvt. Ltd.

INDUSTRY

lead

OcuCure Therapeutics, Inc.

INDUSTRY

NCT02735369 - A Study Assessing Efficacy and Safety of OC-10X in the Treatment of PDR | Biotech Hunter | Biotech Hunter